Ajanta Pharma Limited CC-Jun25.pdf
28 Jul 2025
-
Hi, sir. Sir, somewhere in the middle of the call, you mentioned about some comments on the cardiac division, that about why our growth rate is lower than the IPM. I think you referred to some pricing related thing. Can you just elaborate on that particular part, why the division growth was lower than IPM? That's it. Thanks.
Read in transcript -
Any specific category of products or any prices in the market, which led to that or something?
Read in transcript -
And according to you, it will take more than 2 odd quarters, 2 to 4 quarters is what you have assumed, that means this would resume or maybe start beating the IPM, maybe in FY...
Read in transcript